FKBP公司
钙调神经磷酸酶
活动站点
结合位点
肽基脯氨酰异构酶
化学
丝氨酸
苏氨酸
蛋白质结构
生物物理学
生物化学
磷酸化
生物
酶
移植
异构酶
医学
外科
作者
Charles R. Kissinger,Hans E. Parge,Daniel R. Knighton,Cristina Lewis,Laura A. Pelletier,Anna Tempczyk,Vincent J. Kalish,Kathleen D. Tucker,Richard E. Showalter,Ellen W. Moomaw,Louis N. Gastinel,Noriyuki Habuka,Xinghai Chen,Fausto Maldonado,John E. Barker,Russell J. Bacquet,J. Ernest Villafranca
出处
期刊:Nature
[Springer Nature]
日期:1995-12-01
卷期号:378 (6557): 641-644
被引量:749
摘要
CALCINEURIN (CaN) is a calcium- and ca 1modulin-dependent protein serine/threonine phosphatase which is critical for several important cellular processes, including T-cell activation1. CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cyto-plasmic binding proteins (cyclophilin and FKBP12, respectively)2. We report here the crystal structures of full-length human CaN at 2.1 A resolution and of the complex of human CaN with FKBP12-FK506 at 3.5 A resolution. In the native CaN structure, an auto-inhibitory element binds at the Zn/Fe-containing active site. The metal-site geometry and active-site water structure suggest a catalytic mechanism involving nucleophilic attack on the substrate phosphate by a metal-activated water molecule. In the FKBP12–FK506–CaN complex, the auto-inhibitory element is displaced from the active site. The site of binding of FKBP12–FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein.
科研通智能强力驱动
Strongly Powered by AbleSci AI